Caris Life Sciences Inc (CAI) Q4 2025 Earnings Call Highlights: Record Revenue Surge and ... [Yahoo! Finance]
Caris Life Sciences, Inc. (CAI)
Last caris life sciences, inc. earnings: 10/29 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.capps.com/investor-relations
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Total Revenue: Increased 125% year over year to $293 million in Q4 2025. Molecular Profiling Services Revenue: Increased 199% year over year to $282 million in Q4 2025. Pharma R&D Services Revenue: $10.8 million in Q4 2025. Gross Margin: Improved to 75% on a GAAP basis in Q4 2025, up from 54% in Q4 2024. Net Income: Positive GAAP net income of $82 million in Q4 2025. Adjusted EBITDA: $106 million in Q4 2025. Free Cash Flow: Positive free cash flow of $39.7 million in Q4 2025. Cash on Hand: Grew to slightly above $800 million, an increase of $43 million in the quarter. Full Year Revenue: Increased 97% for the full year 2025. Molecular Profiling Full Year Revenue: Increased 120% to $766.7 million in 2025. Clinical Case Volumes: Grew 22% year over year to approximately 199,300 profiles in 2025. Average Sales Price (ASP): Tissue ASP increased by 83% to over $4,000; Blood ASP increased by 69% to just under $2,800. 2026 Rev
Show less
Read more
Impact Snapshot
Event Time:
CAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAI alerts
High impacting Caris Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
CAI
News
- Assessing Caris Life Sciences (CAI) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Caris Life Sciences (CAI) had its price target lowered by BTIG Research from $45.00 to $38.00. They now have a "buy" rating on the stock.MarketBeat
- Caris Life Sciences (CAI) had its price target raised by Robert W. Baird from $26.00 to $28.00. They now have an "outperform" rating on the stock.MarketBeat
- Caris Life Sciences (CAI) Adds New AI-powered Breast Cancer Signature to its Report [Yahoo! Finance]Yahoo! Finance
CAI
Earnings
- 2/26/26 - Beat
CAI
Sec Filings
- 3/3/26 - Form 10-K
- 3/2/26 - Form 4
- 2/27/26 - Form 4
- CAI's page on the SEC website